# OnCo record checkmate-026 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/checkmate-026/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "checkmate-026", "NCT02041533" ;
  schema:name "CheckMate 026"@en ;
  schema:description "The trial that showed a PD-1 antibody can fail in the first line if the PD-L1 threshold is set too low, and the reason the 50 percent cut-off exists."@en ;
  schema:url <https://onco.cc/trials/checkmate-026/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02041533>, <https://doi.org/10.1056/NEJMoa1613493> ;
  onco:status "negative" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/pdl1-high-nsclc/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/>, <https://onco.cc/technologies/companion-diagnostic/>, <https://onco.cc/technologies/platinum/> ;
  onco:targets <https://onco.cc/targets/pd1/>, <https://onco.cc/targets/pdl1/> ;
  onco:drugs <https://onco.cc/drugs/nivolumab/>, <https://onco.cc/drugs/carboplatin/>, <https://onco.cc/drugs/cisplatin/> ;
  onco:companies <https://onco.cc/companies/bms/> ;
  onco:terms <https://onco.cc/terms/tps/>, <https://onco.cc/terms/pd-l1-testing/> ;
  onco:trials <https://onco.cc/trials/keynote-024-189/>, <https://onco.cc/trials/checkmate-227/>, <https://onco.cc/trials/checkmate-9la/> .